NCT03525431View on ClinicalTrials.gov

Clinical Utility of Pediatric Whole Exome Sequencing

NACompletedINTERVENTIONAL
Enrollment

529

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

May 13, 2022

Study Completion Date

May 13, 2022

Conditions
EncephalopathyBirth DefectIntellectual DisabilityMultiple Congenital AnomalyMetabolic DiseaseEpilepsyNeuro-Degenerative DiseaseCerebral PalsyDevelopmental DelayDevelopmental Defect
Interventions
DIAGNOSTIC_TEST

Whole Exome Sequencing

Whole Exome Sequencing is a form of Next Generation Sequencing allowing investigators to assess the coding regions of many thousands of genes to find variants implicated in disease.

Trial Locations (4)

93701

UCSF Fresno, Fresno

94110

Zuckerberg San Francisco General Hospital, San Francisco

94158

Benioff Children's Hospital Mission Bay, San Francisco

94609

UCSF Benioff Children's Hospital Oakland, Oakland

All Listed Sponsors
collaborator

National Human Genome Research Institute (NHGRI)

NIH

lead

University of California, San Francisco

OTHER

NCT03525431 - Clinical Utility of Pediatric Whole Exome Sequencing | Biotech Hunter | Biotech Hunter